On October 31, the DISARM project will be presented at the IPO Lisbon Research Meeting, introducing a major step forward in the early detection of ovarian cancer.

✍️Sign up here: lnkd.in/dTfRAinJ

#HaDEA #CancerMission

That’s a wrap on the #DISARM kick-off in Athens!

2 days of collaboration, keynotes & big ideas:
🏛️ Ovarian cancer socioececonomic burden & the CanRisk tool
🔬 Liquid biopsy & clinical studies
🧬 PRS adaptation
👥 Citizen awareness & Platforms

An Exciting journey ahead , thank you to all partners! 💙

Day 2 of the #DISARM kick-off in Athens! 🏛️

We open with a keynote from Prof. Antonis Antoniou (University of Cambridge) on the CanRisk tool.

Today’s agenda: risk assessment in clinical studies, citizen awareness, strategies for adapting PRS to national populations and more!

Day 1 of the #DISARM kick-off is complete! 🚀

This afternoon, partners aligned on clinical protocols and explored opportunities for policy development.

More updates coming tomorrow, stay tuned!

A busy and engaging morning here in Athens, with an insightful keynote presentation from Clara MacKay on the socioeconomic burden of ovarian cancer 📰

This was followed by a fruitful discussion on liquid biopsy detection from our partners UNRF 👨‍🏫

Stay tuned for more updates throughout the day!

καλημέρα από Αθήνα 🇬🇷

This morning our Project Partners have gathered in Greece for the Disarm kick off meeting.

This morning's highlight is a keynote presentation from the World Ovarian Cancer Coalition on ‘The Socioeconomic Burden of Ovarian Cancer’. ⚕️

➡️ Follow for more updates!

The DISARM consortium is looking forward to meeting in Athens on 2–3 October for our official kick-off! 🇬🇷

We’re bringing partners together from across Europe to set the stage for advancing ovarian cancer risk assessment & early detection 🧬

Stay tuned for updates from Athens!

What a team! 📸

On Monday, the DISARM consortium held a pre–kick-off online meeting to align on admin, financial & work package details, setting a strong base before our in-person kick-off in Athens next month. 🇬🇷

Stay tuned for more from our kick-off!

#HorizonEurope #OvarianCancer

Perhaps it's fitting that DISARM launched during Gynaecological Cancer Awareness month ♀️

Ovarian cancer is the deadliest gynaecological disease & 8th most common cancer for women globally.

We are changing how risk is assessed, bringing proven tech to routine care while validating new approaches💙

We are proud to launch DISARM, a new Horizon Europe project tackling #OvarianCancer through earlier detection and better risk assessment 🧬♀️

With proven solutions & testing new innovations, DISARM aims to transform screening and give patients the best chance at survival 💙